Tenon Medical, Inc. (TNON)
NASDAQ: TNON · Real-Time Price · USD
0.512
+0.019 (3.92%)
At close: Jun 26, 2026, 4:00 PM EDT
0.495
-0.017 (-3.28%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Tenon Medical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Tenon Medical stock have an average target of 2.63, with a low estimate of 2.25 and a high estimate of 3.00. The average target predicts an increase of 413.67% from the current stock price of 0.51.
Analyst Consensus: Buy
* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for Tenon Medical stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Aug '25 | Oct '25 | Nov '25 | Mar '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $3 | Buy | Reiterates | $3 | +485.94% | May 14, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $2.5 → $2.25 | Buy | Maintains | $2.5 → $2.25 | +339.45% | May 13, 2026 |
Financial Forecast
Revenue This Year
6.59M
from 3.94M
Increased by 67.08%
Revenue Next Year
9.71M
from 6.59M
Increased by 47.38%
EPS This Year
-0.85
from -1.70
EPS Next Year
-0.61
from -0.85
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.0M | 11.6M | |
| Avg | 6.6M | 9.7M | |
| Low | 6.2M | 7.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 77.5% | 76.1% | |
| Avg | 67.1% | 47.4% | |
| Low | 56.7% | 18.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.85 | -0.61 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.